Try our beta test site
46 studies found for:    mesothelioma | United States, California
Show Display Options
Rank Status Study
1 Withdrawn A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: VEGF-Antisense Oligonucleotide , Pemetrexed, Cisplatin
2 Recruiting Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Pleural Epithelioid Mesothelioma;   Pleural Malignant Mesothelioma
Interventions: Radiation: Hypofractionated Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
3 Completed
Has Results
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: belinostat;   Other: laboratory biomarker analysis
4 Unknown  High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Conditions: Breast Cancer;   Endometrial Cancer;   Malignant Mesothelioma
Intervention: Drug: megestrol acetate
5 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
6 Recruiting Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Conditions: Recurrent Pleural Malignant Mesothelioma;   Stage IV Pleural Mesothelioma
Intervention: Drug: Nintedanib
7 Completed Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Conditions: Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer;   Thymoma and Thymic Carcinoma
Intervention: Procedure: radiofrequency ablation
8 Active, not recruiting Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Biological: Immunotherapy plus chemotherapy;   Biological: Immunotherapy with cyclophosphamide plus chemotherapy
9 Completed PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: PTK787/ZK 222584
10 Completed
Has Results
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Condition: Malignant Mesothelioma
Intervention: Drug: everolimus
11 Completed S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Intervention: Drug: gemcitabine hydrochloride
12 Active, not recruiting Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Conditions: Lung Cancer;   Lung Cancer Non-Small Cell Cancer (NSCLC);   Lung Cancer Small Cell Lung Cancer (SCLC);   Mesothelioma
Interventions: Procedure: Stereotactic Body Radiation Therapy (SBRT);   Drug: Iohexol;   Radiation: Computed Tomography (CT);   Device: Cyberknife;   Device: Trilogy;   Device: True Beam
13 Active, not recruiting Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
Condition: Unresectable Pleural or Peritoneal Malignant Mesothelioma
Interventions: Drug: Tremelimumab;   Drug: Placebo
14 Completed Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
15 Active, not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Epithelioid Mesothelioma;   Pleural Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma
Interventions: Drug: Cediranib Maleate;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Pemetrexed Disodium;   Other: Placebo
16 Completed An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: MORAb-009 (Amatuximab);   Drug: Pemetrexed;   Drug: Cisplatin
17 Recruiting Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Conditions: Mesothelioma;   BAP1 Loss of Function
Intervention: Drug: Tazemetostat
18 Terminated
Has Results
Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
Conditions: Epithelioid Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma;   Stage II Pleural Mesothelioma;   Stage III Pleural Mesothelioma;   Stage IV Pleural Mesothelioma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Tivantinib
19 Recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
Conditions: Advanced Malignant Solid Neoplasm;   Advanced Peritoneal Malignant Mesothelioma;   Advanced Pleural Malignant Mesothelioma;   Recurrent Malignant Solid Neoplasm;   Recurrent Peritoneal Malignant Mesothelioma;   Recurrent Pleural Malignant Mesothelioma;   Stage III Non-Small Cell Lung Cancer;   Stage III Ovarian Cancer;   Stage III Pleural Mesothelioma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Pleural Mesothelioma;   Thymoma;   Unresectable Solid Neoplasm
Interventions: Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Methoxyamine;   Drug: Pemetrexed Disodium;   Other: Pharmacological Study
20 Withdrawn Ixabepilone and Pemetrexed/Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: Ixabepilone;   Drug: Pemetrexed

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.